Wanbury Ltd. benchmarking: Performance to industry peers

Financial

	Wanbury	Anuh Pharma	Fredun Pharma
Operational Metrics
Financials
5 yr Average ROE	58.3 %	15.87 %	11.84 %
5yr average Equity Multiplier	-1.35	1.62	2.85
5yr Average Asset Turnover Ratio	1.54	1.35	1.08
5yr Avg Net Profit Margin	5.09 %	7.23 %	3.9 %
Price to Book	13.6	2.24	5.97
P/E	18.76	17.52	28.74
5yr Avg Cash Conversion Cycle	-103.0 Days	42.81 Days	175.29 Days
Inventory Days	21.96 Days	50.87 Days	146.68 Days
Days Receivable	61.39 Days	111.12 Days	142.46 Days
Days Payable	194.51 Days	117.6 Days	112.95 Days
5yr Average Interest Coverage Ratio	2.13	48.66	2.62
5yr Avg ROCE	-37.9 %	21.17 %	22.71 %
5yr Avg Operating Profit Margin	7.72 %	10.21 %	9.7 %
5 yr average Debt to Equity	0.2	0.02	0.93
5yr CAGR Net Profit	n/a	10.73 %	25.5 %
5yr Average Return on Assets	7.92 %	9.84 %	4.18 %
Shareholdings
Promoter Holding	43.07 %	71.82 %	43.06 %
Share Pledged by Promoters	62.18 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	3.23 %	1.23 %	-7.28 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Wanbury	Anuh Pharma	Fredun Pharma
Product Wise Break-Up	Product Wise Break-Up API`s & Formulation 100.0 Bulk drug and Chemicals 0 0	Product Wise Break-Up Bulk drug and Chemicals 100.0 API`s & Formulation 0 0	Product Wise Break-Up Bulk drug and Chemicals 0 API`s & Formulation 0 Pharmaceutical 100.0
Segment Break-Up	Segment Break-Up Pharmaceuticals 100.0	-	-
Location Wise Break-Up	Location Wise Break-Up India 30.27 Rest of the World 0 Others 69.73	Location Wise Break-Up India 45.02 Rest of the World 0 Others 54.98	Location Wise Break-Up India 83.13 Rest of the World 16.86 Others 0.01